Rigel Pharmaceuticals, Inc. (RIGL)
34.61
+0.39
(+1.14%)
USD |
NASDAQ |
Feb 13, 14:14
Rigel Pharmaceuticals Free Cash Flow : 68.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nektar Therapeutics | -190.35M |
| Ironwood Pharmaceuticals, Inc. | 67.65M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
| Catalyst Pharmaceuticals, Inc. | 234.54M |
| Amicus Therapeutics, Inc. | 9.691M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 24.03M |
| Cash from Investing (Quarterly) | -33.18M |
| Cash from Financing (Quarterly) | 4.271M |
| Free Cash Flow Per Share (Quarterly) | 1.254 |
| Free Cash Flow to Equity (Quarterly) | 24.18M |
| Free Cash Flow to Firm (Quarterly) | 25.93M |
| Free Cash Flow Yield | 10.72% |